Skip to main content

MISSION Therapeutics

Cambridge, United Kingdom

MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.

$13.3M raised
Oct 2025
Venture - Series Unknown

Top Investors

Sofinnova PartnersSR OneRevelation PartnersInnovate UKMichael J. Fox Foundation

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about MISSION Therapeutics

How much funding has MISSION Therapeutics raised?
MISSION Therapeutics has raised $13.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2025.
Who are MISSION Therapeutics's investors?
MISSION Therapeutics's investors include Sofinnova Partners, SR One, Revelation Partners, Innovate UK, Michael J. Fox Foundation.
Where is MISSION Therapeutics headquartered?
MISSION Therapeutics is headquartered in Cambridge, United Kingdom.
What does MISSION Therapeutics do?
MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.
What stage is MISSION Therapeutics at?
MISSION Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"MISSION Therapeutics — Funding & Investors." VCBacked, October 15, 2025, https://www.vcbacked.co/company/mission-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2025). MISSION Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/mission-therapeutics
Wikipedia (cite web)
{{cite web |title=MISSION Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mission-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .